Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
A Score-Based Approach to .

Diagnostics (Basel, Switzerland)

Bauckneht M, Morbelli S, Fiz F, Ferrarazzo G, Piva R, Nieri A, Sarocchi M, Spallarossa P, Canepari ME, Arboscello E, Bellodi A, Massaia M, Gallamini A, Bruzzi P, Marini C, Sambuceti G.
PMID: 29072629
Diagnostics (Basel). 2017 Oct 26;7(4). doi: 10.3390/diagnostics7040057.

PURPOSE: To verify the capability of METHODS: 36 patients underwent FDG-PET/CT. These patients had shown full remission after DXR-based chemotherapy for Hodgkin's disease (DXR dose: 40-50 mg/m² per cycle), and were retrospectively enrolled. Inclusion criteria implied the presence of...

Cite
Bauckneht M, Morbelli S, Fiz F, et al. A Score-Based Approach to . Diagnostics (Basel). 2017;7(4)doi: 10.3390/diagnostics7040057.
Bauckneht, M., Morbelli, S., Fiz, F., Ferrarazzo, G., Piva, R., Nieri, A., Sarocchi, M., Spallarossa, P., Canepari, M. E., Arboscello, E., Bellodi, A., Massaia, M., Gallamini, A., Bruzzi, P., Marini, C., & Sambuceti, G. (2017). A Score-Based Approach to . Diagnostics (Basel, Switzerland), 7(4), . https://doi.org/10.3390/diagnostics7040057
Bauckneht, Matteo, et al. "A Score-Based Approach to ." Diagnostics (Basel, Switzerland) vol. 7,4 (2017). doi: https://doi.org/10.3390/diagnostics7040057
Bauckneht M, Morbelli S, Fiz F, Ferrarazzo G, Piva R, Nieri A, Sarocchi M, Spallarossa P, Canepari ME, Arboscello E, Bellodi A, Massaia M, Gallamini A, Bruzzi P, Marini C, Sambuceti G. A Score-Based Approach to . Diagnostics (Basel). 2017 Oct 26;7(4). doi: 10.3390/diagnostics7040057. PMID: 29072629; PMCID: PMC5745393.
Copy Download .nbib Format: NLM
Revision of the subgenus Orthoscymnus Canepari of Scymnus Kugelann (Coleoptera, Coccinellidae), with descriptions of four new species.

ZooKeys

Chen X, Canepari C, Wang X, Ren S.
PMID: 26865817
Zookeys. 2016 Jan 13;(552):91-107. doi: 10.3897/zookeys.552.6167. eCollection 2016.

The subgenus Orthoscymnus Canepari, 1997 of Scymnus Kugelann, 1794 is herein revised. Seven species of the Orthoscymnus fauna are recognized, of which four species, Scymnus (Orthoscymnus) jilongicus sp. n., Scymnus (Orthoscymnus) paradoxus sp. n., Scymnus (Orthoscymnus) crispatus sp. n....

Cite
Chen X, Canepari C, Wang X, et al. Revision of the subgenus Orthoscymnus Canepari of Scymnus Kugelann (Coleoptera, Coccinellidae), with descriptions of four new species. Zookeys. 2016;(552):91-107doi: 10.3897/zookeys.552.6167.
Chen, X., Canepari, C., Wang, X., & Ren, S. (2016). Revision of the subgenus Orthoscymnus Canepari of Scymnus Kugelann (Coleoptera, Coccinellidae), with descriptions of four new species. ZooKeys, (552), 91-107. https://doi.org/10.3897/zookeys.552.6167
Chen, Xiaosheng, et al. "Revision of the subgenus Orthoscymnus Canepari of Scymnus Kugelann (Coleoptera, Coccinellidae), with descriptions of four new species." ZooKeys vol. ,552 (2016): 91-107. doi: https://doi.org/10.3897/zookeys.552.6167
Chen X, Canepari C, Wang X, Ren S. Revision of the subgenus Orthoscymnus Canepari of Scymnus Kugelann (Coleoptera, Coccinellidae), with descriptions of four new species. Zookeys. 2016 Jan 13;(552):91-107. doi: 10.3897/zookeys.552.6167. eCollection 2016. PMID: 26865817; PMCID: PMC4740851.
Copy Download .nbib Format: NLM
Choline Metabolism Alteration: A Focus on Ovarian Cancer.

Frontiers in oncology

Bagnoli M, Granata A, Nicoletti R, Krishnamachary B, Bhujwalla ZM, Canese R, Podo F, Canevari S, Iorio E, Mezzanzanica D.
PMID: 27446799
Front Oncol. 2016 Jun 22;6:153. doi: 10.3389/fonc.2016.00153. eCollection 2016.

Compared with normal differentiated cells, cancer cells require a metabolic reprograming to support their high proliferation rates and survival. Aberrant choline metabolism is a fairly new metabolic hallmark reflecting the complex reciprocal interactions between oncogenic signaling and cellular metabolism....

Cite
Bagnoli M, Granata A, Nicoletti R, et al. Choline Metabolism Alteration: A Focus on Ovarian Cancer. Front Oncol. 2016;6:153doi: 10.3389/fonc.2016.00153.
Bagnoli, M., Granata, A., Nicoletti, R., Krishnamachary, B., Bhujwalla, Z. M., Canese, R., Podo, F., Canevari, S., Iorio, E., & Mezzanzanica, D. (2016). Choline Metabolism Alteration: A Focus on Ovarian Cancer. Frontiers in oncology, 6153. https://doi.org/10.3389/fonc.2016.00153
Bagnoli, Marina, et al. "Choline Metabolism Alteration: A Focus on Ovarian Cancer." Frontiers in oncology vol. 6 (2016): 153. doi: https://doi.org/10.3389/fonc.2016.00153
Bagnoli M, Granata A, Nicoletti R, Krishnamachary B, Bhujwalla ZM, Canese R, Podo F, Canevari S, Iorio E, Mezzanzanica D. Choline Metabolism Alteration: A Focus on Ovarian Cancer. Front Oncol. 2016 Jun 22;6:153. doi: 10.3389/fonc.2016.00153. eCollection 2016. PMID: 27446799; PMCID: PMC4916225.
Copy Download .nbib Format: NLM
In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer.

Frontiers in oncology

Canese R, Mezzanzanica D, Bagnoli M, Indraccolo S, Canevari S, Podo F, Iorio E.
PMID: 27446810
Front Oncol. 2016 Jun 28;6:164. doi: 10.3389/fonc.2016.00164. eCollection 2016.

Epithelial ovarian cancer (EOC) is the gynecological malignancy with the highest death rate, characterized by frequent relapse and onset of drug resistance. Disease diagnosis and therapeutic follow-up could benefit from application of molecular imaging approaches, such as magnetic resonance...

Cite
Canese R, Mezzanzanica D, Bagnoli M, et al. In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer. Front Oncol. 2016;6:164doi: 10.3389/fonc.2016.00164.
Canese, R., Mezzanzanica, D., Bagnoli, M., Indraccolo, S., Canevari, S., Podo, F., & Iorio, E. (2016). In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer. Frontiers in oncology, 6164. https://doi.org/10.3389/fonc.2016.00164
Canese, Rossella, et al. "In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer." Frontiers in oncology vol. 6 (2016): 164. doi: https://doi.org/10.3389/fonc.2016.00164
Canese R, Mezzanzanica D, Bagnoli M, Indraccolo S, Canevari S, Podo F, Iorio E. In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer. Front Oncol. 2016 Jun 28;6:164. doi: 10.3389/fonc.2016.00164. eCollection 2016. PMID: 27446810; PMCID: PMC4923069.
Copy Download .nbib Format: NLM
Odyssey of Multivalent Cathode Materials: Open Questions and Future Challenges.

Chemical reviews

Canepa P, Sai Gautam G, Hannah DC, Malik R, Liu M, Gallagher KG, Persson KA, Ceder G.
PMID: 28269988
Chem Rev. 2017 Mar 08;117(5):4287-4341. doi: 10.1021/acs.chemrev.6b00614. Epub 2017 Feb 13.

The rapidly expanding field of nonaqueous multivalent intercalation batteries offers a promising way to overcome safety, cost, and energy density limitations of state-of-the-art Li-ion battery technology. We present a critical and rigorous analysis of the increasing volume of multivalent...

Cite
Canepa P, Sai Gautam G, Hannah DC, et al. Odyssey of Multivalent Cathode Materials: Open Questions and Future Challenges. Chem Rev. 2017;117(5):4287-4341doi: 10.1021/acs.chemrev.6b00614.
Canepa, P., Sai Gautam, G., Hannah, D. C., Malik, R., Liu, M., Gallagher, K. G., Persson, K. A., & Ceder, G. (2017). Odyssey of Multivalent Cathode Materials: Open Questions and Future Challenges. Chemical reviews, 117(5), 4287-4341. https://doi.org/10.1021/acs.chemrev.6b00614
Canepa, Pieremanuele, et al. "Odyssey of Multivalent Cathode Materials: Open Questions and Future Challenges." Chemical reviews vol. 117,5 (2017): 4287-4341. doi: https://doi.org/10.1021/acs.chemrev.6b00614
Canepa P, Sai Gautam G, Hannah DC, Malik R, Liu M, Gallagher KG, Persson KA, Ceder G. Odyssey of Multivalent Cathode Materials: Open Questions and Future Challenges. Chem Rev. 2017 Mar 08;117(5):4287-4341. doi: 10.1021/acs.chemrev.6b00614. Epub 2017 Feb 13. PMID: 28269988.
Copy Download .nbib Format: NLM
Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients.

Oncotarget

Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, Valeri B, Libra M, Barbareschi M, Raspagliesi F, Mezzanzanica D, Canevari S.
PMID: 26002433
Oncotarget. 2015 Apr 30;6(12):9643. doi: 10.18632/oncotarget.3998.

No abstract available.

Cite
Bagnoli M, De Cecco L, Granata A, et al. Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget. 2015;6(12):9643doi: 10.18632/oncotarget.3998.
Bagnoli, M., De Cecco, L., Granata, A., Nicoletti, R., Marchesi, E., Alberti, P., Valeri, B., Libra, M., Barbareschi, M., Raspagliesi, F., Mezzanzanica, D., & Canevari, S. (2015). Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget, 6(12), 9643. https://doi.org/10.18632/oncotarget.3998
Bagnoli, Marina, et al. "Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients." Oncotarget vol. 6,12 (2015): 9643. doi: https://doi.org/10.18632/oncotarget.3998
Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, Valeri B, Libra M, Barbareschi M, Raspagliesi F, Mezzanzanica D, Canevari S. Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget. 2015 Apr 30;6(12):9643. doi: 10.18632/oncotarget.3998. PMID: 26002433; PMCID: PMC4496384.
Copy Download .nbib Format: NLM
Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water.

FEMS microbiology ecology

del Mar Lleó M, Tafi MC, Signoretto C, Dal Cero C, Canepari P.
PMID: 10568843
FEMS Microbiol Ecol. 1999 Dec 01;30(4):345-353. doi: 10.1111/j.1574-6941.1999.tb00662.x.

Among the survival strategies developed by bacteria when faced with adverse environmental conditions, the viable but nonculturable (VNC) state has been described. In this state, bacteria are unable to form colonies but are still alive and capable of metabolic...

Cite
del Mar Lleó M, Tafi MC, Signoretto C, et al. Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water. FEMS Microbiol Ecol. 1999;30(4):345-353doi: 10.1111/j.1574-6941.1999.tb00662.x.
del Mar Lleó M, Tafi, M. C., Signoretto, C., Dal Cero C, & Canepari, P. (1999). Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water. FEMS microbiology ecology, 30(4), 345-353. https://doi.org/10.1111/j.1574-6941.1999.tb00662.x
del Mar Lleó M, et al. "Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water." FEMS microbiology ecology vol. 30,4 (1999): 345-353. doi: https://doi.org/10.1111/j.1574-6941.1999.tb00662.x
del Mar Lleó M, Tafi MC, Signoretto C, Dal Cero C, Canepari P. Competitive polymerase chain reaction for quantification of nonculturable Enterococcus faecalis cells in lake water. FEMS Microbiol Ecol. 1999 Dec 01;30(4):345-353. doi: 10.1111/j.1574-6941.1999.tb00662.x. PMID: 10568843.
Copy Download .nbib Format: NLM
[ROUND-TABLE DISCUSSION].

El Dia medico

CANEVARI M.
PMID: 14055613
Dia Med. 1963 Aug 01;35:1160.

No abstract available.

Cite
CANEVARI M. ESA REDONDA. [ROUND-TABLE DISCUSSION]. Dia Med. 1963;35:1160
CANEVARI, M. (1963). ESA REDONDA. [ROUND-TABLE DISCUSSION]. El Dia medico, 351160.
CANEVARI, M. "ESA REDONDA." [ROUND-TABLE DISCUSSION]. El Dia medico vol. 35 (1963): 1160.
CANEVARI M. ESA REDONDA. [ROUND-TABLE DISCUSSION]. Dia Med. 1963 Aug 01;35:1160. Spanish. PMID: 14055613.
Copy Download .nbib Format: NLM
Modeling speech imitation and ecological learning of auditory-motor maps.

Frontiers in psychology

Canevari C, Badino L, D'Ausilio A, Fadiga L, Metta G.
PMID: 23818883
Front Psychol. 2013 Jun 27;4:364. doi: 10.3389/fpsyg.2013.00364. Print 2013.

Classical models of speech consider an antero-posterior distinction between perceptive and productive functions. However, the selective alteration of neural activity in speech motor centers, via transcranial magnetic stimulation, was shown to affect speech discrimination. On the automatic speech recognition...

Cite
Canevari C, Badino L, D'Ausilio A, et al. Modeling speech imitation and ecological learning of auditory-motor maps. Front Psychol. 2013;4:364doi: 10.3389/fpsyg.2013.00364.
Canevari, C., Badino, L., D'Ausilio, A., Fadiga, L., & Metta, G. (2013). Modeling speech imitation and ecological learning of auditory-motor maps. Frontiers in psychology, 4364. https://doi.org/10.3389/fpsyg.2013.00364
Canevari, Claudia, et al. "Modeling speech imitation and ecological learning of auditory-motor maps." Frontiers in psychology vol. 4 (2013): 364. doi: https://doi.org/10.3389/fpsyg.2013.00364
Canevari C, Badino L, D'Ausilio A, Fadiga L, Metta G. Modeling speech imitation and ecological learning of auditory-motor maps. Front Psychol. 2013 Jun 27;4:364. doi: 10.3389/fpsyg.2013.00364. Print 2013. PMID: 23818883; PMCID: PMC3694210.
Copy Download .nbib Format: NLM
Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.

Journal of medicinal chemistry

Menichincheri M, Ardini E, Magnaghi P, Avanzi N, Banfi P, Bossi R, Buffa L, Canevari G, Ceriani L, Colombo M, Corti L, Donati D, Fasolini M, Felder E, Fiorelli C, Fiorentini F, Galvani A, Isacchi A, Borgia AL, Marchionni C, Nesi M, Orrenius C, Panzeri A, Pesenti E, Rusconi L, Saccardo MB, Vanotti E, Perrone E, Orsini P.
PMID: 31424209
J Med Chem. 2019 Sep 12;62(17):8364. doi: 10.1021/acs.jmedchem.9b01259. Epub 2019 Aug 19.

No abstract available.

Cite
Menichincheri M, Ardini E, Magnaghi P, et al. Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. J Med Chem. 2019;62(17):8364doi: 10.1021/acs.jmedchem.9b01259.
Menichincheri, M., Ardini, E., Magnaghi, P., Avanzi, N., Banfi, P., Bossi, R., Buffa, L., Canevari, G., Ceriani, L., Colombo, M., Corti, L., Donati, D., Fasolini, M., Felder, E., Fiorelli, C., Fiorentini, F., Galvani, A., Isacchi, A., Borgia, A. L., Marchionni, C., Nesi, M., Orrenius, C., Panzeri, A., Pesenti, E., Rusconi, L., Saccardo, M. B., Vanotti, E., Perrone, E., & Orsini, P. (2019). Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. Journal of medicinal chemistry, 62(17), 8364. https://doi.org/10.1021/acs.jmedchem.9b01259
Menichincheri, Maria, et al. "Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor." Journal of medicinal chemistry vol. 62,17 (2019): 8364. doi: https://doi.org/10.1021/acs.jmedchem.9b01259
Menichincheri M, Ardini E, Magnaghi P, Avanzi N, Banfi P, Bossi R, Buffa L, Canevari G, Ceriani L, Colombo M, Corti L, Donati D, Fasolini M, Felder E, Fiorelli C, Fiorentini F, Galvani A, Isacchi A, Borgia AL, Marchionni C, Nesi M, Orrenius C, Panzeri A, Pesenti E, Rusconi L, Saccardo MB, Vanotti E, Perrone E, Orsini P. Correction to Discovery of Entrectinib: A New 3-Aminoindazole as a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. J Med Chem. 2019 Sep 12;62(17):8364. doi: 10.1021/acs.jmedchem.9b01259. Epub 2019 Aug 19. PMID: 31424209.
Copy Download .nbib Format: NLM
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells.

Oncotarget

Di Stefano C, Grazioli P, Fontanella RA, De Cesaris P, D'Amore A, Regno M, Starace D, Padula F, Fiori ME, Canipari R, Stoppacciaro A, Pesce M, Filippini A, Campese AF, Ziparo E, Riccioli A.
PMID: 30112117
Oncotarget. 2018 Jul 20;9(56):30905-30918. doi: 10.18632/oncotarget.25773. eCollection 2018 Jul 20.

In human prostate cancer (PCa), the neuroendocrine cells, expressing the prostate cancer stem cell (CSC) marker CD44, may be resistant to androgen ablation and promote tumor recurrence. During the study of heterogeneity of the highly aggressive neuroendocrine PCa cell...

Cite
Di Stefano C, Grazioli P, Fontanella RA, et al. Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells. Oncotarget. 2018;9(56):30905-30918doi: 10.18632/oncotarget.25773.
Di Stefano, C., Grazioli, P., Fontanella, R. A., De Cesaris, P., D'Amore, A., Regno, M., Starace, D., Padula, F., Fiori, M. E., Canipari, R., Stoppacciaro, A., Pesce, M., Filippini, A., Campese, A. F., Ziparo, E., & Riccioli, A. (2018). Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells. Oncotarget, 9(56), 30905-30918. https://doi.org/10.18632/oncotarget.25773
Di Stefano, Chiara, et al. "Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells." Oncotarget vol. 9,56 (2018): 30905-30918. doi: https://doi.org/10.18632/oncotarget.25773
Di Stefano C, Grazioli P, Fontanella RA, De Cesaris P, D'Amore A, Regno M, Starace D, Padula F, Fiori ME, Canipari R, Stoppacciaro A, Pesce M, Filippini A, Campese AF, Ziparo E, Riccioli A. Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells. Oncotarget. 2018 Jul 20;9(56):30905-30918. doi: 10.18632/oncotarget.25773. eCollection 2018 Jul 20. PMID: 30112117; PMCID: PMC6089404.
Copy Download .nbib Format: NLM
The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response.

Cancer communications (London, England)

Devecchi A, De Cecco L, Dugo M, Penso D, Dagrada G, Brich S, Stacchiotti S, Sensi M, Canevari S, Pilotti S.
PMID: 30486883
Cancer Commun (Lond). 2018 Nov 28;38(1):70. doi: 10.1186/s40880-018-0339-3.

BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare, aggressive, and poorly investigated simple sarcoma with a low frequency of genetic deregulation other than an Ewing sarcoma RNA binding protein 1 (EWSR1)-Wilm's tumor suppressor (WT1) translocation. We used...

Cite
Devecchi A, De Cecco L, Dugo M, et al. The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer Commun (Lond). 2018;38(1):70doi: 10.1186/s40880-018-0339-3.
Devecchi, A., De Cecco, L., Dugo, M., Penso, D., Dagrada, G., Brich, S., Stacchiotti, S., Sensi, M., Canevari, S., & Pilotti, S. (2018). The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer communications (London, England), 38(1), 70. https://doi.org/10.1186/s40880-018-0339-3
Devecchi, Andrea, et al. "The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response." Cancer communications (London, England) vol. 38,1 (2018): 70. doi: https://doi.org/10.1186/s40880-018-0339-3
Devecchi A, De Cecco L, Dugo M, Penso D, Dagrada G, Brich S, Stacchiotti S, Sensi M, Canevari S, Pilotti S. The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response. Cancer Commun (Lond). 2018 Nov 28;38(1):70. doi: 10.1186/s40880-018-0339-3. PMID: 30486883; PMCID: PMC6260689.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries